Your SlideShare is downloading. ×
Pulmonary Embolism
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.

Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pulmonary Embolism


Published on

Published in: Health & Medicine

  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Pulmonary Embolism  Prof. M.C.Bansal  MBBS;MS. FICOG. MICOG.  Founder Principal & Controller, Jhalawar Medical College and Hospital Jhalawar.  Ex Principal and Controller,  Mahatma Gandhi Medical College & hosptal ; Sitapura Jaipur.
  • 2. Introduction  It is not an uncommon cause of MMR— responsible for 10%MMR.  Occurs as 1:7000 pregnancy.  Incidence are equal in ANC and purperium , but MMR is more in delivered women.  70% 0f women developing PE have pre existing DVT.  50% of DVT cases may develop silent PE due to dislodgement of small / tiny thrombus.
  • 3. PE Clinical Presentation  Massive embolism i.e. obstruction of >50% of pulmonary arterial circulation is likely to be associated with right side heart failure.  Massive embolism leads to haemodynamic instability. Increased pulmonary vascular resistance and hypertension,which develops when 60-70 % pulmonary vascular tree is occluded by embolus . Right ventricular dilatation develops.  Not to forget PE may be silent
  • 4. Investigations  Ventilation perfusion scintigraphy (lung scan )  MRI  Pulmonary angiography.  Echo cardiography.  X ray chest PA & lateral view.  ECG .  Diagnostic tests for Coagulation and fibrinolysis.  PO2 studies in pulmonary and aortic circulation .
  • 5. Diagnostic Tests--  Clinical examination alone is able to confirm only 20-30% of cases of DVT  BloodTests  the D-dimer  International Normalised Ratio (INR).  Current D-dimer assays have predictive value for DVT, and PE  INR is useful for guiding the management of patients with known DVT who are on warfarin (Coumadin)
  • 6.  Xray Chest--Loss of vascular markings in the lung field where blood circulation is blocked by embolus. Atelectasis, hemidiaphragm elevation , pleural effusion.  Echocardiography ---- dilatation of right ventricle., increased pulmonary vascular resistance and pulmonary hypertension.  ECG---Right axis deviationT wave inversion in anterior chest leads. Sinus tachycardia,S1 Q3T 3 pattern.
  • 7. D-dimmer  D-dimmer is a specific degradation product of cross-linked fibrin. Because concurrent production and breakdown of clot characterize thrombosis, patients with thromboembolic disease have elevated levels of D-dimer  three major approaches for measuring D- dimer  ELISA  latex agglutination  blood agglutination test
  • 8.  recent (within 10 days) surgery or trauma,  recent myocardial infarction or stroke,  acute infection,  disseminated intravascular coagulation,  pregnancy or recent delivery,  active collagen vascular disease, or metastatic cancer False-positive D-dimers  occur in patients with PE D – Dimer tests to be done ---
  • 9. Embolus in Pulmonary Trunk
  • 10. Pulmonary Embolism
  • 11. Pulmonary Embolism